Positive expression of NR6A1/CT150 as a predictor of biochemical recurrence-free survival in prostate cancer patients

NR6A1/CT150, as an orphan receptor, is a novel member of the cancer-testis (CT) antigen family. Here, we investigated the expression and function of NR6A1 and its underlying mechanisms in prostate cancer (PCa) patients who underwent radical prostatectomy. A total of 303 cases of prostate cancer afte...

Descripción completa

Detalles Bibliográficos
Autores principales: Cheng, Gong, Wang, Shangqian, Li, Xiao, Li, Shuang, Zheng, Yang, Zhang, Lei, Bao, Meiling, Liang, Chao, Huang, Zhengkai, Liu, Yiyang, Qin, Chao, Shao, Pengfei, Li, Jie, Hua, Lixin, Yin, Changjun, Wang, Zengjun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Clinical Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5610014/
https://www.ncbi.nlm.nih.gov/pubmed/28969082
http://dx.doi.org/10.18632/oncotarget.11749

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5610014/
https://www.ncbi.nlm.nih.gov/pubmed/28969082
http://dx.doi.org/10.18632/oncotarget.11749

Ejemplares similares